Abstract
Currently cardiac biomarkers such as B-type natriuretic peptide (BNP) and N-terminal peptide (NT-proBNP) were widely used to diagnose HF in dyspnoea patients. NT-proBNP is not only also useful for the diagnosis of uncertain dyspnoea patients, but it also plays a crucial role to determine the short-term prognosis of heart failure patients This present study is to assess the role of NT-proBNP as a predicting factor for mortality inpatient admitted with Acute Heart Failure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
